Cargando…
Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
It is estimated that by the year 2050 there will be more than 1.5 billion people globally over the age of 65 years. Aging is associated with changes to a number of different cellular processes which are driven by a variety of factors that contribute to the characteristic decline in function that is...
Autores principales: | Adlard, Paul A., Bush, Ashley I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870044/ https://www.ncbi.nlm.nih.gov/pubmed/29562528 http://dx.doi.org/10.3233/JAD-170662 |
Ejemplares similares
-
Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
por: Prasanna, Pragya, et al.
Publicado: (2021) -
Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019) -
Understanding Bioluminescence in Dinoflagellates—How Far Have We Come?
por: Valiadi, Martha, et al.
Publicado: (2013) -
Candida glabrata Biofilms: How Far Have We Come?
por: Rodrigues, Célia F., et al.
Publicado: (2017) -
Gene Delivery to the Skin – How Far Have We Come?
por: Ain, Qurrat Ul, et al.
Publicado: (2021)